BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17327435)

  • 21. Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: the Insulin Resistance Atherosclerosis Family Study.
    Gallagher CJ; Langefeld CD; Gordon CJ; Campbell JK; Mychaleckyj JC; Bryer-Ash M; Rich SS; Bowden DW; Sale MM
    Diabetes; 2007 Aug; 56(8):2135-41. PubMed ID: 17513703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
    Bonomo JA; Ng MC; Palmer ND; Keaton JM; Larsen CP; Hicks PJ; ; Langefeld CD; Freedman BI; Bowden DW
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1434-40. PubMed ID: 24948143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptor alpha gene variants associate with type 2 diabetes and fasting plasma glucose.
    Dahlman I; Vaxillaire M; Nilsson M; Lecoeur C; Gu HF; Cavalcanti-Proença C; Efendic S; Ostenson CG; Brismar K; Charpentier G; Gustafsson JA; Froguel P; Dahlman-Wright K; Steffensen KR
    Pharmacogenet Genomics; 2008 Nov; 18(11):967-75. PubMed ID: 18854778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
    Bailey JNC; Palmer ND; Ng MCY; Bonomo JA; Hicks PJ; Hester JM; Langefeld CD; Freedman BI; Bowden DW
    Hum Genet; 2014 Jun; 133(6):769-779. PubMed ID: 24385048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of nitric oxide and endothelin in end-stage renal disease.
    Freedman BI; Yu H; Anderson PJ; Roh BH; Rich SS; Bowden DW
    Nephrol Dial Transplant; 2000 Nov; 15(11):1794-800. PubMed ID: 11071967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).
    Iyengar SK; Sedor JR; Freedman BI; Kao WH; Kretzler M; Keller BJ; Abboud HE; Adler SG; Best LG; Bowden DW; Burlock A; Chen YD; Cole SA; Comeau ME; Curtis JM; Divers J; Drechsler C; Duggirala R; Elston RC; Guo X; Huang H; Hoffmann MM; Howard BV; Ipp E; Kimmel PL; Klag MJ; Knowler WC; Kohn OF; Leak TS; Leehey DJ; Li M; Malhotra A; März W; Nair V; Nelson RG; Nicholas SB; O'Brien SJ; Pahl MV; Parekh RS; Pezzolesi MG; Rasooly RS; Rotimi CN; Rotter JI; Schelling JR; Seldin MF; Shah VO; Smiles AM; Smith MW; Taylor KD; Thameem F; Thornley-Brown DP; Truitt BJ; Wanner C; Weil EJ; Winkler CA; Zager PG; Igo RP; Hanson RL; Langefeld CD;
    PLoS Genet; 2015 Aug; 11(8):e1005352. PubMed ID: 26305897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of the proprotein convertase subtilisin/kexin-type 2 (PCSK2) gene with type 2 diabetes in an African American population.
    Leak TS; Keene KL; Langefeld CD; Gallagher CJ; Mychaleckyj JC; Freedman BI; Bowden DW; Rich SS; Sale MM
    Mol Genet Metab; 2007; 92(1-2):145-50. PubMed ID: 17618154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic analysis of diabetic nephropathy on chromosome 18 in African Americans: linkage analysis and dense SNP mapping.
    McDonough CW; Bostrom MA; Lu L; Hicks PJ; Langefeld CD; Divers J; Mychaleckyj JC; Freedman BI; Bowden DW
    Hum Genet; 2009 Dec; 126(6):805-17. PubMed ID: 19690890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study.
    Hanson RL; Craig DW; Millis MP; Yeatts KA; Kobes S; Pearson JV; Lee AM; Knowler WC; Nelson RG; Wolford JK
    Diabetes; 2007 Apr; 56(4):975-83. PubMed ID: 17395743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular screening and association studies of retinoid-related orphan receptor gamma (RORC): a positional and functional candidate for type 2 diabetes.
    Wang H; Chu W; Das SK; Zheng Z; Hasstedt SJ; Elbein SC
    Mol Genet Metab; 2003 Jul; 79(3):176-82. PubMed ID: 12855222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
    Cooke JN; Bostrom MA; Hicks PJ; Ng MC; Hellwege JN; Comeau ME; Divers J; Langefeld CD; Freedman BI; Bowden DW
    Nephrol Dial Transplant; 2012 Apr; 27(4):1505-11. PubMed ID: 21968013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans.
    McDonough CW; Hicks PJ; Lu L; Langefeld CD; Freedman BI; Bowden DW
    Hum Genet; 2009 Aug; 126(2):265-75. PubMed ID: 19373489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation at the SLC12A3 locus is unlikely to explain risk for advanced diabetic nephropathy in Caucasians with type 2 diabetes.
    Ng DP; Nurbaya S; Choo S; Koh D; Chia KS; Krolewski AS
    Nephrol Dial Transplant; 2008 Jul; 23(7):2260-4. PubMed ID: 18263927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common variants in glutamine:fructose-6-phosphate amidotransferase 2 (GFPT2) gene are associated with type 2 diabetes, diabetic nephropathy, and increased GFPT2 mRNA levels.
    Zhang H; Jia Y; Cooper JJ; Hale T; Zhang Z; Elbein SC
    J Clin Endocrinol Metab; 2004 Feb; 89(2):748-55. PubMed ID: 14764791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
    Kao WH; Klag MJ; Meoni LA; Reich D; Berthier-Schaad Y; Li M; Coresh J; Patterson N; Tandon A; Powe NR; Fink NE; Sadler JH; Weir MR; Abboud HE; Adler SG; Divers J; Iyengar SK; Freedman BI; Kimmel PL; Knowler WC; Kohn OF; Kramp K; Leehey DJ; Nicholas SB; Pahl MV; Schelling JR; Sedor JR; Thornley-Brown D; Winkler CA; Smith MW; Parekh RS;
    Nat Genet; 2008 Oct; 40(10):1185-92. PubMed ID: 18794854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
    Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
    Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of the estrogen receptor alpha (ESR1) gene and the risk of Alzheimer's disease in a southern Chinese community.
    Ma SL; Tang NL; Tam CW; Lui VW; Lau ES; Zhang YP; Chiu HF; Lam LC
    Int Psychogeriatr; 2009 Oct; 21(5):977-86. PubMed ID: 19586561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease.
    Friedman DJ; Talbert ME; Bowden DW; Freedman BI; Mukanya Y; Enjyoji K; Robson SC
    Diabetes; 2009 Apr; 58(4):999-1006. PubMed ID: 19095759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.
    Freedman BI; Hicks PJ; Sale MM; Pierson ED; Langefeld CD; Rich SS; Xu J; McDonough C; Janssen B; Yard BA; van der Woude FJ; Bowden DW
    Nephrol Dial Transplant; 2007 Apr; 22(4):1131-5. PubMed ID: 17205963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia.
    Weickert CS; Miranda-Angulo AL; Wong J; Perlman WR; Ward SE; Radhakrishna V; Straub RE; Weinberger DR; Kleinman JE
    Hum Mol Genet; 2008 Aug; 17(15):2293-309. PubMed ID: 18424448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.